<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320660">
  <stage>Registered</stage>
  <submitdate>29/09/2009</submitdate>
  <approvaldate>30/09/2009</approvaldate>
  <actrnumber>ACTRN12609000845235</actrnumber>
  <trial_identification>
    <studytitle>Pharmacokinetics of 0.25% levobupivacaine with adrenaline following caudal epidural administration in children</studytitle>
    <scientifictitle>A non-randomised single group study on the pharmokinetics of 0.25% levobupivacaine with adrenaline administered caudally in children undergoing elective sub-umbilical surgical procedures for which caudal epidural analgesia is indicated</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Children undergoing elective sub-umbilical surgical procedures for which caudal epidural analgesia is indicated.</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will receive 0.25% levobupivacaine in a volume to be determined by the attending anaesthetist with adrenaline 5 mcg/mL via the caudal route, under general anaesthesia. This will be administered as a single shot caudal.</interventions>
    <comparator>Not applicable as this is a single group study</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To establish the pharmacokinetics of levobupivacaine via the caudal route, when administered with adrenaline. We will obtain up to 6 blood samples per patient and the samples will be batch-analysed for serum levobupivacaine levels at the Biochemistry laboratory at the Royal Melbourne Hospital. NONMEM population pharmacokinetic modelling will be used to analyse this data.</outcome>
      <timepoint>5, 10, 20, 30, 60, &gt;90 minutes post-injection</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>N/A</outcome>
      <timepoint>N/A</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusion criteria:
1. Children aged under 18 years.
2. Subumbilical surgery planned.
3. Caudal analgesia with levobupivacaine and adrenaline regarded as acceptable standard of care by treating anaesthetist (or by independent anaesthetist where conflict of interest arises between research and treating anaesthetist)</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>18</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Exclusion criteria: 1. Caudal analgesia refused by parent/guardian. 2. Allergy to levobupivacaine/drug solution excipients. 3. Administration of levobupivacaine or adrenaline via any route in 72 hours prior to, or any extra administration during, the study period.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Pharmacokinetics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>15/10/2009</anticipatedstartdate>
    <actualstartdate>8/12/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>2/06/2011</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Children's Hospital</primarysponsorname>
    <primarysponsoraddress>Flemington Road
Parkville, Victoria, 3052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Children's Hospital</fundingname>
      <fundingaddress>Flemington Road
Parkville, Victoria, 3052</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to determine how adrenaline affects the absorption of levobupivacaine in children having caudal anaesthesia for sub-umbilical surgery. Our study hypothesis is that the absorption of levobupivacaine will be affected when administered in conjunction with adrenaline via the caudal route.</summary>
    <trialwebsite />
    <publication>Chalkiadis GA, Abdullah F, Bjorksten AR, Clarke A, Cortinez LI, Udayasiri S, Anderson BJ. Absorption characteristics of epidural levobupivacaine with adrenaline and clonidine in children. Paediatr Anaesth. 2013 Jan;23(1):58-67. </publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Children's Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Flemington Road, Parkville Victoria 3052</ethicaddress>
      <ethicapprovaldate>19/11/2009</ethicapprovaldate>
      <hrec>29101</hrec>
      <ethicsubmitdate>24/08/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr George Chalkiadis</name>
      <address>Department of Anaesthesia and Pain Management, Royal Children's Hospital
Flemington Road,
Parkville
Victoria 3052</address>
      <phone>+61 3 9345 5233</phone>
      <fax>+61 3 9345 6003</fax>
      <email>george.chalkiadis@rch.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr George Chalkiadis</name>
      <address>Department of Anaesthesia and Pain Management, Royal Children's Hospital
Flemington Road,
Parkville
Victoria 3052</address>
      <phone>+61 3 9345 5233</phone>
      <fax>+61 3 9345 6003</fax>
      <email>george.chalkiadis@rch.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Suzette Sheppard</name>
      <address>Department of Anaesthesia and Pain Management, Royal Children's Hospital
Flemington Road,
Parkville
Victoria 3052</address>
      <phone>+61 3 9345 4901</phone>
      <fax>+61 3 9345 6003</fax>
      <email>suzette.sheppard@mcri.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>George Chalkiadis</name>
      <address>Department of Anaesthesia and Pain Management
Royal Children's Hospital
Flemington Road
Parkville
VIC 3052</address>
      <phone>+61393455233</phone>
      <fax />
      <email>george.chalkiadis@rch.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>